Advertisement
An inhaled version of the Parkinson's drug levodopa can help when patients experience symptoms between doses of the pill form of the medication

Inhaled Levodopa May Rapidly Relieve Parkinson’s Symptoms

0
Levodopa pill can wear off, but a powdered version can help patients during off periods
Severe fatigue can impede social reintegration in Hodgkin's lymphoma survivors

Social Reintegration of Hodgkin’s Survivors Impeded by Fatigue

0
Significant negative association of severe fatigue and employment among male and female survivors
The majority of anaphylaxis patients seeking treatment in Belgian emergency departments are treated in accordance with the European Academy of Allergy and Clinical Immunology guidelines

Most Anaphylaxis Patients in ER Treated Appropriately

0
But, rates low for Rx adrenaline auto-injector for self-administration at discharge
Some antihypertensive medications may increase the risk that patients will be hospitalized for depression and bipolar disorder

Some Antihypertensives Linked to Depression, Bipolar Risk

0
Research suggests possible differential effects of antihypertensive medications on mood
Dietary calcium in the form of supplements

Calcium Supplements May Be Detrimental to Heart Health

0
Higher incidence of coronary artery calcification in people who take calcium supplements
Children whose mothers used a selective serotonin reuptake inhibitor during pregnancy may be more likely to develop speech and language disorders

SSRI Use During Pregnancy Tied to Speech Issues in Offspring

0
No link found between SSRI use in pregnancy and risk of motor disorders, poor academic performance
A radiomic-based approach can be used to generate a prediction model for stratifying treatment outcome among patients with recurrent glioblastoma prior to bevacizumab treatment

Radiomic-Based Method Predicts Recurrent Glioblastoma Outcome

0
Radiomic-based superpc signature stratifies patients into low- or high-risk groups for PFS, OS
Pembrolizumab is associated with longer progression-free and overall survival for patients with non-small-cell lung cancer with programmed death ligand 1 expression on at least 50 percent of tumor cells

Pembrolizumab Ups Survival in NSCLC With PD-L1 Expression

0
Findings in patients with advanced NSCLC with PD-L1 expression on at least 50 percent of tumor cells
The duration of disease-free survival is increased with sunitinib treatment for patients with locoregional

Renal-Cell Cancer Disease-Free Survival Up With Sunitinib

0
Findings in patients with locoregional, high-risk clear-cell renal-cell carcinoma
When a hospital patient is taking antibiotics

CDI Risk Up When Prior Occupant of Hospital Bed Got Antibiotics

0
Researchers find an association with elevated risk of Clostridium difficile infection